Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2007, p. 939-946, Vol. 73, No. 3
0099-2240/07/$08.00+0 doi:10.1128/AEM.02016-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Key Laboratory of Biotechnology and Crop Quality Improvement, Ministry of Agriculture, Biotechnology Research Center, Southwest University, 400716 Chongqing, China
Received 25 August 2006/ Accepted 20 November 2006
|
|
|---|
|
|
|---|
Plant seeds are usually scattered in environments rich in microorganisms. To protect their seeds from the invasion of pathogens, plants have developed various defense systems during their evolution (26). The physical barriers of seeds, e.g., lower water content and hard seed shell, against bacterial and fungal invasion are destroyed during seed germination because the seed coat is ruptured by imbibition. The breakage of these physical barriers can allow the invasion of pathogens into seeds (44). Therefore, seed germination is a period vulnerable to pathogen attack in a plant's life cycle (26, 45). It is widely accepted that antimicrobial peptides or proteins participate in the protection of seeds against potential microbial invaders during their germination (7, 26, 43-45). Until now, in plant seeds many proteins with antimicrobial activities have been detected, including chitinases and ß-1,3-glucanases (24, 28), defensins (6, 46), thionins (15), lipid transfer proteins (7, 8), 2S albumins (1, 44), and ribosome-inactivating proteins (3, 10, 35). These antimicrobial proteins may be employed to create pathogenic resistance in transgenic plants (1, 21).
Motherwort (Leonurus japonicus Houtt) is a medicinal herb used in China as a traditional emmenagogue (an agent that promotes menstrual discharge) and an antipyretic and is now known to produce valuable products which have potential application in the treatment of various diseases (9, 29, 30). However, so far the antimicrobial ingredients in motherwort have been poorly investigated. In screening for potent antimicrobial proteins from various plant seeds, we found that the extract from motherwort seeds exhibits strong inhibition of growth of the fungal pathogens tested. We purified an antimicrobial protein from the extract and found that the protein is small in molecular mass (7.8 kDa) and heat stable. Furthermore, this seed protein has not only antifungal but also antibacterial activities, indicating that this is a novel seed protein. The expression of the gene encoding this protein enhanced resistance to fungal and bacterial pathogens in transformed tobacco.
|
|
|---|
Antimicrobial assays.
All bacterial and
fungal strains used in this study were kindly provided by the
Department of Plant Pathology, Southwest University. For antifungal
activity assays, 17 fungal species were used as listed in Table
1. All fungi were grown in potato dextrose broth (Difco), except
Saccharomyces cerevisiae was cultivated in YPD (2% peptone, 1%
yeast extract, 2% glucose and 2% agar, pH 5.8). The antifungal assay in
vitro was performed as previously described
(50). The determination
of the concentration required for a 50% inhibition of fungal growth
(IC50) was performed by liquid growth inhibition assays
(41). For the
antibacterial assay, the four bacterial species in Table
1, grown in Luria-Bertani
medium at 28°C, were employed as previously described
(42). The antifungal
activity to inhibit conidial germination of fungi was measured by
placing 20-µl conidial suspensions (1.5 x
106 conidia/ml) in 40 µl potato dextrose broth
containing the sample on a sterile glass sheet. Conidial germination
was directly examined on the glass sheet after 8 h of
incubation in a moist chamber at
28°C.
|
View this table: [in a new window] |
TABLE 1. Antimicrobial
activity of
LJAMP1a
|
Electrophoresis and amino acid sequence determination.
Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) was carried out on 0.75-mm-thick slab
gels containing a 15.5% polyacrylamide separating gel with a 4%
stacking gel using an electrophoresis cell (Amersham Biosciences,
Sweden) according to the manufacturer's instructions. Polypeptide
molecular mass markers and silver staining reagents were from Amersham
Biosciences (Sweden). Protein concentration was measured by the
Bradford method (5) using
bovine serum albumin as a standard. The purified sample was subjected
to SDS-PAGE as above and then electroblotted to a polyvinylidene
difluoride membrane (Bio-Rad). Protein bands were visualized with
Coomassie blue R and excised from the membrane. The N-terminal amino
acid sequence determination was performed by the Laboratory for Protein
Chemistry of Hunan Normal University (Changsha, China) on a protein
sequencer (model no. 491; Applied
Biosystems).
Gene cloning and RNA analyses.
Based on the
N-terminal amino acid sequence, a degenerate primer,
5'-CCG CAG CAG CAG AC(ATCG) GT(ATCG)
GA(AG)-3', was designed. 3' rapid
amplification of cDNA ends (RACE) was performed with a 3' full
RACE kit (Takara, Japan) according to the manufacturer's instructions.
The amplified product was purified and cloned into pGEM-T (Promega, WI)
for sequencing. To amplify the 5' flanking sequence of the
gene, the Y-shaped adaptor-dependent extension (YADE) method
(49) was employed. Based
on the nucleotide sequence of the 3' RACE products, two nested
primers (A,
5'-GCTGTGACCTTAATCCGCAA-3', and
B, 5'-GCATCCTAGCCTTTCGATAC-3')
were designed. The Y-shaped adaptor with a blunt terminus was produced
by annealing equal molarities of oligonucleotides
5'-CGGTAGGATCCCGCAGAACGACGGCCAG-3'and 5'-pCTGGCCGTCCAAGACGC-3'.
Around 10 ng DraI-/SmaI-digested genomic DNA of motherwort was ligated
to 4 µl of adaptor (8 µM), and then 1 µl of
ligation products containing about 0.5 ng of genomic DNA was used as a
template to sequentially perform linear amplification and exponential
amplification. The reaction of linear amplification contained 1
µl of ligation products, 1x PCR buffer, 200 µM
deoxynucleoside triphosphates, 1.5 mM MgCl2, 200 µM
primer A, and 1 U Taq DNA polymerase (added when the reaction
temperature rose to 94°C). The reaction started at 94°C
for 5 min, and the following cycle was repeated 40 times: 94°C
for 30 s, 56°C for 30 s, 72°C for 2
min, and a final extension at 72°C for 5 min. Finally, linear
amplification products (1 µl) were used as the template of the
exponential amplification with the adaptor primer
(5'-CGGTAGGATCCCGCAGAAC-3') and
nested primer B. The reactions were amplified using a step-down PCR
protocol (18), with one
step for 5 min at 94°C, followed by 12 cycles at 94°C
for 30 s, 58°C (decreasing 0.5°C per cycle)
for 30 s, and 72°C for 2 min, then 30 cycles at
94°C for 30 s, 52°C for 30 s, and
72°C for 2 min, followed by 72°C for 10 min. The YADE
product was purified and cloned into pGEM-T (Promega, Madison,WI) for
sequencing. The products of YADE and the 3' RACE
sequence were overlapped with the SeqMan program of DNASTAR
(DNASTAR, Madison, Wisconsin), and the contig sequence was further used
to perform a similarity search with the BLASTX program to determine the
putative initiator ATG. The coding region of the LJAMP1 gene was
further amplified from the genomic DNA using the primers
5'-GCAGTCAAATGCTGCAGGGT-3' and
5'-GCCGATAGGCCTTAATCATC-3'.
Total RNAs were extracted from various motherwort tissues and tobacco leaves using the guanidinium thiocyanate method (27). Northern blot hybridizations were carried out with 32P-labeled LJAMP1 cDNA probes using the Ready-To-Go random primer labeling kit (Amersham Biosciences, Sweden) as previously described (40).
Vector construction and plant transformation.
The open reading frame region
encoding LJAMP1 was cloned to downstream of the CaMV 35S
promoter. The nos transcription terminator was placed
downstream. Then the expression cassette with the CaMV 35S
promoter-LJAMP1-nos terminator and CaMV 35S
promoter-gus-nos terminator and Nos
promoter-npt II (neomycin phosphotransferase II
gene)-nos terminator were cloned in the binary
vector pBIN19
(16). The construct was
delivered into Agrobacterium tumefaciens LBA4404
(19) by the
freeze-thawing method (2),
and the resulting Agrobacterium strain was used for the
transformation of tobacco leaf disk by cocultivation
(25). The transgenic
plants were regenerated under kanamycin selection (100 mg/liter) as
previously described
(20).
Analyses on transgenic tobacco.
For
protein analysis, tobacco seeds were incubated at 26°C in a
rotary shaker (170 rpm) for 3 days and then the germinating seeds were
grown in sterile soil in multiwell plastic containers that were kept in
a growth chamber at 80% relative humidity, from 25°C to
28°C, under a 14-h/10-h photoperiod at 150
µE/s/m2). Fresh leaf tissues (10 g) of tobacco were
homogenized with 10 ml of buffer A containing 50 mM KCl, 5 mM EDTA, 1
mM aprotinin, and 20 mM thiourea. To identify the transgene products,
the samples were analyzed by HPLC on a SOURCE 5RPC reversed-phase
column (4.6 by 150 mm, 5 µm; Amersham Biosciences, Sweden)
equilibrated with 0.05% TFA using an ÄKTA explorer 10S (Amersham
Biosciences, Sweden), with 0.05% TFA over 5 min and a linear gradient
of 0 to 45% acetonitrile in 0.05% TFA over 35 min at a flow rate of 1.0
ml/min.
To test the resistance of transgenic tobacco to infection
by Alternaria alternata, the bioassay was performed. A.
alternata strain was grown on potato dextrose agar at room
temperature for 2 to 3 weeks. Spores were harvested in sterile tap
water, counted with the hemocytometer, and then diluted to 1 x
106 spores/ml. Phytopathogenic fungus inoculation of tobacco
was carried out by spraying the A. alternata spore suspension
(1 x 106 spores/ml in sterile water) on leaves of
4-week-old plants. The inoculated plants were placed in a growth
chamber at 90% relative humidity and 28°C for 3 days and
further incubated at 80% relative humidity and 28°C for 7 days.
Then the numbers and sizes of lesions on leaves were scored, and the
variation of lesions was reflected by a five-class disease severity
scale (DS) defined as follows: DS class 0, no lesion; DS class 1, mean
size of lesions less than 1 mm; DS class 2, mean size of lesions from 1
to 2 mm; DS class 3, mean size of lesions from 2 to 5 mm; and DS class
4, mean size of lesions more than 5 mm. Disease resistance was
expressed using a disease index (DI). The DI was calculated using the
following formula: DI (%) = (
I x
j/4 x n) x 100, where i is
the DS class, j is the number of disease leaves in each class,
and n is the total number of leaves. Each treatment was
replicated three times, and each replicate contained 18
plants.
To determine whether the overexpression of LJAMP1 in tobacco can provide resistance to the bacterial pathogen, we infected the tobacco plants with a Ralstonia solanacearum isolate, which causes bacterial wilt disease on tobacco. The bacterium was grown for 48 h at 30°C on Luria-Bertani medium. The bacterial suspension for inoculation was prepared by washing the medium surface with sterile tap water, and the bacterial population was adjusted to 107 cells/ml. Tobacco plants (4 weeks old) were inoculated by dipping the roots into the bacterial suspensions. The plants were kept in a growth chamber at 95% relative humidity and 28°C for 2 days and then at 80% relative humidity and 28°C for 6 days. The number of wilting leaves was recorded for each plant daily, and a five-class disease severity scale was calculated based on the previously described method (22). Each treatment was replicated three times, and each replicate contained 20 plants.
All data were analyzed by t test (P
0.05) using the software Origin v6 (OriginLab
Co.).
Nucleotide sequence accession number.
The nucleotide
sequence data reported for the LJAMP1 gene were deposited in
GenBank Nucleotide Sequence Databases under the GenBank accession
number
AAW66631.
|
|
|---|
![]() View larger version (24K): [in a new window] |
FIG. 1. Purification
of LJAMP1. (a) The adsorbed fraction from a carboxymethylcellulose
cation-exchange column was subjected to reversed-phase chromatography
using HPLC on a C8 semipreparation column. (b) The P3
fraction shown in panel a was purified on an Aquapore OD-300 analytical
C18 reversed-phase column. (c) Analysis by SDS-PAGE of the
peak shown in panel b. Lane 1, 2.6 µg protein from the peak in
panel b; lane 2, polypeptide molecular mass
markers.
|
![]() View larger version (56K): [in a new window] |
FIG. 2. Antimicrobial
activity of LJAMP1 in vitro. (a) Inhibition of growth on
plate for the fungus R. cerealis and the bacterium R.
solanacearum. LJAMP1 was added at concentrations of 7.5
µM (1), 15 µM (2), and 25 µM (3). Bovine serum
albumin was added at concentrations of 7.5 µM (4), 15
µM (5), and 25 µM (6). Buffer A is also shown (7). (b)
Effect on germination of spores for phytopathogenic fungus B.
maydis. (c) Effect on germination of spores and growth of hyphae
for phytopathogenic fungus A. brassicae. Spores and hyphae
were incubated in potato dextrose broth medium with LJAMP1 at a final
concentration of 15 µM and without LJAMP1 (control).
Photomicrographs
were taken after 6 h of incubation of B. maydis (b)
and A. brassicae (c). In panels b and c, parts A and B, the
scale bar indicates 100 µm; in panel c, parts C to F, the scale
bar indicates 20
µm.
|
![]() View larger version (12K): [in a new window] |
FIG. 3. Dose-response
effect of LJAMP1 in in vitro antifungal assays. Dose-response curves
were derived from in vitro microtiter plate assays with LJAMP1 after
incubation for 48 h at 26°C. Fungi tested were A.
alternata ( ), C. personata ( ), A.
niger (x), and S. cerevisiae ( ). Each
data point represents the mean of experiments (n = 4
each) performed three
times.
|
![]() View larger version (57K): [in a new window] |
FIG. 4. Nucleotide
sequence and deduced amino acid sequence of the full-length
LJAMP1 cDNA. (a) The cDNA gene sequence encoding LJAMP1. The
deduced amino acid sequence is shown in one-letter code under the DNA
sequence. The initiation codon and poly(A) are underlined.
The deduced signal peptide sequence is italic, and the determined
N-terminal amino acid sequence of mature LJAMP1 is bold.(b) Amino acid sequence alignment of LJAMP1 (accession no.
AAW66631) with napin-like proteins from sesame
(Sesamum indicum, accession no.
AAK15088), balsam pear (Momordica
charantia, accession no. CAD32398), and
black walnut (Juglans nigra, accession no.
AY102930). Protein sequences were aligned with
the ClustalW algorithm. The ID column shows the identity of the protein
sequences.
|
![]() View larger version (58K): [in a new window] |
FIG. 5. RNA
gel blot analysis of LJAMP1 transcripts in different tissues
of motherwort. Total RNAs were extracted from leaves, stems, and roots
of 5-week-old plants and from the seeds at the 30th (seed 1) and 50th
(seed 2) days after anthesis. RNAs electrophoresed in a 1% agarose gel
containing 6% formaldehyde were hybridized with a
32P-labeled LJAMP1 cDNA probe.
Hybridizing signals were visualized by exposing the membrane to X-ray
film (top). The gel was stained with ethidium bromide to detect rRNAs
as control (bottom). The relative density rate (%) represents the
relative percentages of LJAMP1 mRNA/rRNA in different
tissues.
|
We randomly selected seven homozygous transgenic T2 lines with a single insert of the transgene for subsequent molecular analyses. Hybridization with LJAMP1 cDNA revealed different levels of accumulation of LJAMP1 transcripts in transgenic plants (Fig. 6a). Strong hybridization signals were seen in the transgenic lines R1, R2, and R13, moderate signals in lines R14, R15, and R19, and a weak signal in line R16. To detect the gene products of LJAMP1 in transgenic tobacco plants, the protein extracts from the leaves of all transgenic lines were subjected to HPLC and the HPLC profiles of the samples were compared with that of the purified LJAMP1. The LJAMP1-specific peak, which showed inhibition activity against R. solanacearum (data not shown), was detected in the transgenic lines, while no such peak was found in the control (Fig. 6b), indicating that LJAMP1 had been expressed stably in the transgenic tobacco plants.
![]() View larger version (39K): [in a new window] |
FIG. 6. The
expression analysis of LJAMP1 in transgenic tobacco seedlings. (a) RNA
gel blot analysis of LJAMP1 transcripts in transgenic tobacco
seedlings. As a control, tobacco was transformed with an empty vector.
The relative density rate (%) represents the relative percentages of
LJAMP1 mRNA/rRNA in different lines. (b) HPLC profiles of
proteins from transgenic lines control, R1 and R15, and the purified
LJAMP1. Arrows indicate LJAMP1
peaks.
|
![]() View larger version (13K): [in a new window] |
FIG. 7. Resistance
of transgenic T2 tobacco plants inoculated with the fungus
A. alternata and the bacterium R. solanacearum. (a)
Fungal infection assays of tobacco plants holding LJAMP1. Mean
values of disease indexes (%) estimated from four independent infection
assays (nine plants per line) are shown. (b) Bacterial infection assays
of tobacco transformed with LJAMP1. Mean values of disease
indexes (%) estimated from three independent infection assays (12
plants per line) are shown. Asterisks indicate that the DI in
transgenic lines was significantly different (P values was
0.05 by t test) compared with that of the DI in the
control. Error bars indicate standard
deviations.
|
|
|
|---|
Napins, a member of the 2S albumin class of proteins, which are water-extractable storage proteins in seeds, are encoded by a gene family (4) and usually composed of a 4.5-kDa small subunit and a 10-kDa large subunit (17). They are derived from proteolytic cleavage of a precursor of about 180 amino acid residues (12, 33). However, some napin-like proteins were reported to be single-chain proteins. For instance, charantin, an RIP isolated from balsam pear, is a single-chain peptide and structurally related to the large chain of the napin-like proteins (36). Although the major function of napins is devoted to storage (4), some napins or napin-like proteins possess significant antifungal or antibacterial properties (4, 32). Our bioassay showed that LJAMP1 inhibits the growth of an array of both fungi and bacteria. Furthermore, we also assayed the efficacy of LJAMP1 in inhibiting the mycelial growth and spore germination of B. maydis and A. brassicae (Fig. 2b and c). In a comparison of the antimicrobial potencies of different antimicrobial proteins from plants, LJAMP1 displays a satisfied inhibitory effect (IC50 values from 17 to 52 µg/ml) against A. alternata, C. personata, and A. niger. For example, the growth inhibition of TRIP, a protein from tobacco, was about 50 µg/ml against a number of fungi and bacteria, and ME, a protein from Mirabilis expansa, is active against Rhizoctonia solani growth at a dose of 10 µg/ml (34).
Genes coding for defense proteins have already been employed to enhance plant resistance against fungal and bacterial phytopathogens (38, 39, 51). For instance, transgenic orange plants expressing a tomato thaumatin-like protein exhibited increased tolerance toward Phytophtora citrophthora (13); constitutive overexpression of an antimicrobial protein gene Ace-AMP1 from Allium cepa in Oryza sativa subsp. indica rice enhanced resistance against three major rice pathogens, Magnaporthe grisea, R. solani, and Xanthomonas oryzae(37); and the expressions of defense-related gene ch5B coding for a chitinase caused the reduction of disease symptoms in strawberry (cultivar Pájaro) infected with Botrytis cinerea (48). To confirm the antifungal and antibacterial function of LJAMP1, we constitutively expressed the LJAMP1 gene in transgenic tobacco. Infection assays for fungal and bacterial pathogens indicated that transgenic tobacco plants were characterized by resistance against R. solanacearum and A. alternata (see Fig. S2 in the supplemental material). The resistance of LJAMP1 in transgenic tobacco against fungal and bacterial diseases confirmed the antifungal and antibacterial effects of LJAMP1 in planta.
Taken together, the results of our study indicated that LJAMP1 is a novel, heat-stable, small single-chain antimicrobial protein with a wide range of antifungal and antibacterial activities. Because there were no visible negative effects on the growth of transgenic plants, LJAMP1 has potential application in plant protection by gene engineering.
This research was supported with funds from the National Natural Science Foundation of China (grant no. 30270147 and 30370916 to X. Yang).
Supplemental material for this article may be found at
http://aem.asm.org/. ![]()
Published ahead of print on 8 December 2006. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»